Your browser doesn't support javascript.
loading
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Glassman, Adam R; Wells, John A; Josic, Kristin; Maguire, Maureen G; Antoszyk, Andrew N; Baker, Carl; Beaulieu, Wesley T; Elman, Michael J; Jampol, Lee M; Sun, Jennifer K.
Affiliation
  • Glassman AR; Jaeb Center for Health Research, Tampa, Florida. Electronic address: drcrstat2@jaeb.org.
  • Wells JA; Palmetto Retina Center, Columbia, South Carolina.
  • Josic K; Jaeb Center for Health Research, Tampa, Florida.
  • Maguire MG; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Antoszyk AN; Charlotte Eye, Ear, Nose and Throat Associates, Charlotte, North Carolina.
  • Baker C; Paducah Retinal Center, Paducah, Kentucky.
  • Beaulieu WT; Jaeb Center for Health Research, Tampa, Florida.
  • Elman MJ; Elman Retina Group, Pikesville, Maryland.
  • Jampol LM; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois.
  • Sun JK; Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts.
Ophthalmology ; 127(9): 1201-1210, 2020 09.
Article in En | MEDLINE | ID: mdl-32402554
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Macular Edema / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Diabetic Retinopathy / Bevacizumab / Ranibizumab Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ophthalmology Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Macular Edema / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Diabetic Retinopathy / Bevacizumab / Ranibizumab Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ophthalmology Year: 2020 Document type: Article